FHM LIFE SCIENCES VIII, L.L.C.'s Net Worth
$66.5 Million
Who is FHM LIFE SCIENCES VIII, L.L.C.?
FHM LIFE SCIENCES VIII, L.L.C. has an estimated net worth of $66.5 Million. This is based on reported shares across multiple companies, which include ALPINE IMMUNE SCIENCES, INC., Arcutis Biotherapeutics, Inc., Sierra Oncology, Inc., Entasis Therapeutics Holdings Inc., and Aptinyx Inc..
SEC CIK
FHM LIFE SCIENCES VIII, L.L.C.'s CIK is 0001698823
Past Insider Trading and Trends
2018 was FHM LIFE SCIENCES VIII, L.L.C.'s most active year for acquiring shares with 8 total transactions. FHM LIFE SCIENCES VIII, L.L.C.'s most active month to acquire stocks was the month of January. 2018 was FHM LIFE SCIENCES VIII, L.L.C.'s most active year for disposing of shares, totalling 6 transactions. FHM LIFE SCIENCES VIII, L.L.C.'s most active month to dispose stocks was the month of August. 2020 saw FHM LIFE SCIENCES VIII, L.L.C. paying a total of $8,500,000.00 for 10,033,758 shares, this is the most they've acquired in one year. In 2020 FHM LIFE SCIENCES VIII, L.L.C. cashed out on 9,583,758 shares for a total of $250,010.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $5.7209
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.92% | 80K |
$2.50 | $200,000.00 | 8.76M |
Oct 24
| |||
Form 4
| +2.96% | 250K |
$20.00 | $5,000,000.00 | 8.68M |
Aug 5
| |||
Form 4
| -20.00% | -2.11M |
—
|
—
| 8.43M |
May 10
| |||
Form 4
| +1,971.14% | 10.03M |
$17.00 |
—
| 10.54M |
Feb 4
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALPINE IMMUNE SCIENCES, INC. (ALPN) Snapshot price: $27.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.22% | 112.67K |
$7.10 | $799,989.10 | 1.48M |
Feb 11
| |||
Form 4
| -46.67% | -1.20M |
—
|
—
| 1.37M |
Sep 17
| |||
Form 4
| +16.94% | 372.44K |
$5.37 | $1,999,997.43 | 2.57M |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entasis Therapeutics Holdings Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.70% | -50.00K |
$5.00 | -$250,010.00 | 1.3M |
Jan 9
| |||
Form 4
| +196.88% | 1.29M |
$15.00 |
—
| 1.94M |
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aptinyx Inc. (APTX) Snapshot price: $0.096
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.19M |
$16.00 |
—
| 3.19M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||